<HTML>


<HEAD>








<TITLE>SECURITIES AND EXCHANGE COMMISSION</TITLE>


<META NAME="doccomm" CONTENT="HOU03:892848.2">


<META NAME="PaperType" CONTENT="Letter (Draft)">


<META NAME="_AdHocReviewCycleID" CONTENT="-351597963">


<META NAME="_EmailSubject" CONTENT="Millennium and  Lyondell Form 8-Ks related to Millennium credit facilities">


<META NAME="_AuthorEmail" CONTENT="Tia.Daniel@Lyondell.com">


<META NAME="_AuthorEmailDisplayName" CONTENT="Daniel, Tia L">


</HEAD>


<BODY LINK="#0000ff" VLINK="#800080">





<B><P ALIGN="CENTER">UNITED STATES</P>


<P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>


<P ALIGN="CENTER">Washington, D.C. 20549</P>


</B><P ALIGN="CENTER"></P>


<B><P ALIGN="CENTER">FORM 8-K</P>


<P ALIGN="CENTER"></P>


</B><P ALIGN="CENTER">Current Report </P>


<P ALIGN="CENTER">Pursuant to Section 13 or 15(d) of the</P>


<P ALIGN="CENTER">Securities Exchange Act of 1934</P>


<P ALIGN="CENTER"></P>


<P ALIGN="CENTER">&nbsp;</P>


<P ALIGN="CENTER">Date of Report (date of earliest event reported): May 24, 2006</P>


<P ALIGN="CENTER"></P>


<P ALIGN="CENTER">&nbsp;</P>


<B><FONT SIZE=5><P ALIGN="CENTER">LYONDELL CHEMICAL COMPANY</P>


</B></FONT><P ALIGN="CENTER">(Exact name of registrant as specified in its charter)</P>


<P ALIGN="CENTER"></P>


<B><P ALIGN="CENTER">Delaware</P>


</B><P ALIGN="CENTER">(State or other jurisdiction of incorporation)</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&#9;<B>1-10145&#9;&#9;&#9;&#9;&#9;&#9;&#9;&#9;95-4160558</P>


</B><P ALIGN="JUSTIFY">(Commission File Number)&#9;&#9;&#9;&#9;&#9;(I.R.S. Employer Identification No.)</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&nbsp;</P>


<B><P ALIGN="JUSTIFY">1221 McKinney Street, Suite 700, Houston, Texas&#9;&#9;&#9;   77010</P>


</B><P ALIGN="JUSTIFY">&#9;(Address of principal executive offices)&#9;&#9;&#9;&#9;(Zip Code)</P>


<P ALIGN="JUSTIFY"></P>


<B><P ALIGN="CENTER">(713) 652-7200</P>


</B><P ALIGN="CENTER">(Registrant's telephone number, including area code)</P>


<P ALIGN="CENTER"></P>


<B><P ALIGN="CENTER">Not Applicable</P>


</B><P ALIGN="CENTER">(Former Name or Former Address, if Changed Since Last Report)</P>


<P ALIGN="CENTER"></P>


<P ALIGN="JUSTIFY">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see </I>General Instruction A.2. below):</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&#9;<FONT FACE="Wingdings">&#111;</FONT>


&#9;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&#9;<FONT FACE="Wingdings">&#111;</FONT>


&#9;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&#9;<FONT FACE="Wingdings">&#111;</FONT>


&#9;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&#9;<FONT FACE="Wingdings">&#111;</FONT>


&#9;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>


<P ALIGN="JUSTIFY">The description set forth below is qualified in its entirety by the full text of the respective document to which it refers, which document is filed herewith.</P>


<B><P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">Item 1.01&#9;Entry into a Material Definitive Agreement</P>


<P ALIGN="JUSTIFY"></P>


</B><P ALIGN="JUSTIFY">Effective May 24, 2006, Millennium Chemicals Inc. ( &quot;Millennium&quot;), a wholly owned subsidiary of Lyondell Chemical Company (&quot;Lyondell&quot;), Millennium America Inc., a U.S. subsidiary of Millennium (&quot;Millennium America&quot;) and Millennium Inorganic Chemicals Ltd, an Australian subsidiary of Millennium (&quot;MIC Ltd&quot;), entered into an amendment (the &quot;Amendment&quot;) to the Credit Agreement (the &quot;Credit Agreement&quot;), dated August 22, 2005, among Millennium, Millennium America, MIC Ltd, the lenders party thereto including Bank of America, N.A. as Syndication Agent, JPMorgan Chase Bank, N.A. as Administrative Agent and Collateral Agent, and J.P. Morgan Securities Inc. and Banc of America Securities LLC as Co-Lead Arrangers and Joint Bookrunners.  The Amendment primarily revised the Credit Agreement to exclude Millennium Holdings, LLC and its subsidiaries (collectively, &quot;Millennium Holdings&quot;), a subsidiary of Millennium, from events-of-default provisions that could be triggered in connection with judgments against Millennium Holdings.  Lyondell has not guaranteed Millennium's or its subsidiaries' obligations under the Credit Agreement.  The Amendment is incorporated by reference into this Current Report on Form 8-K.</P>


<B><P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">Item 9.01&#9;Financial Statements and Exhibits</P>


<OL START=3 TYPE="a">


<DIR>


<DIR>





<OL TYPE="a">





</B><P ALIGN="JUSTIFY"><LI>Exhibits</LI></P></OL>


</DIR>


</DIR>


</OL>


<DIR>


<DIR>


<DIR>


<DIR>


<DIR>


<DIR>





<P>4.27(a)&#9;Amendment No. 1 dated as of May 23, 2006 to Credit Agreement, dated August 22, 2005, among Millennium America Inc., as Borrower, Millennium Inorganic Chemicals Ltd, as Borrower, <A NAME="OLE_LINK1"><A NAME="OLE_LINK2">Millennium Chemicals Inc.</A></A>, as Guarantor, the lenders from time to time party thereto, Bank of America, N.A., as Syndication Agent, JP Morgan Chase Bank, N.A. as Administrative Agent and Collateral Agent and JP Morgan Securities Inc. and Banc of America Securities LLC as Co-Lead Arrangers and Joint Bookrunners (filed as Exhibit 4.4(a) to Millennium's Current Report on Form 8-K dated as of May 24, 2006 and incorporated herein by reference)</P>


<P ALIGN="JUSTIFY"></P></DIR>


</DIR>


</DIR>


</DIR>


</DIR>


</DIR>





<B><P ALIGN="CENTER">SIGNATURE</P>


</B><P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&nbsp;</P>


<P ALIGN="JUSTIFY">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;&#9;&#9;LYONDELL CHEMICAL COMPANY</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&nbsp;</P>


<P ALIGN="JUSTIFY">&nbsp;</P>


<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;&#9;&#9;By:<U>/s/ Kerry A. Galvin&#9;&#9;&#9;</P>


</U><P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;&#9;&#9;Name:&#9;Kerry A. Galvin</P>


<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;&#9;&#9;Title:&#9;Senior Vice President &amp; General &#9;&#9;&#9;&#9;&#9;&#9;&#9;&#9;&#9;Counsel</P>


<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;&#9;&#9;&#9;</P>


<P ALIGN="JUSTIFY"></P>


<P ALIGN="JUSTIFY">&nbsp;</P>


<P ALIGN="JUSTIFY">Date:  May 24, 2006</P>


<FONT FACE="Arial" SIZE=1><P ALIGN="CENTER"></P>


</FONT><B><P ALIGN="CENTER">INDEX TO EXHIBITS</P>


</B><P ALIGN="CENTER"></P>


<P>Exhibit</P>


<U><P>Number</U>&#9;&#9;<U>Description</P>


<DIR>


<DIR>


<DIR>


<DIR>


<DIR>


<DIR>





</U><P ALIGN="JUSTIFY">4.27(a)&#9;Amendment No. 1 dated as of May 23, 2006 to Credit Agreement, dated August 22, 2005, among Millennium America Inc., as Borrower, Millennium Inorganic Chemicals Ltd, as Borrower, Millennium Chemicals Inc., as Guarantor, the lenders from time to time party thereto, Bank of America, N.A., as Syndication Agent, JP Morgan Chase Bank, N.A. as Administrative Agent and Collateral Agent and JP Morgan Securities Inc. and Banc of America Securities LLC as Co-Lead Arrangers and Joint Bookrunners (filed as Exhibit 4.4(a) to Millennium's Current Report on Form 8-K dated as of May 24, 2006 and incorporated herein by reference)</P>


<U>


</U><P ALIGN="JUSTIFY">&nbsp;</P></DIR>


</DIR>


</DIR>


</DIR>


</DIR>


</DIR>


</BODY>


</HTML>
[{"type": "8-K", "sequence": "1", "filename": "rrd119604.htm", "secsgml_size_bytes": 7922}]
{"company-data": {"conformed-name": "LYONDELL CHEMICAL CO", "cik": "0000842635", "assigned-sic": "2860", "irs-number": "954160558", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-10145", "film-number": "06868960"}, "business-address": {"street1": "1221 MCKINNEY ST", "street2": "SUITE 700", "city": "HOUSTON", "state": "TX", "zip": "77010", "phone": "713-652-7200"}, "mail-address": {"street1": "1221 MCKINNEY ST", "street2": "SUITE 700", "city": "HOUSTON", "state": "TX", "zip": "77010"}, "former-company": {"former-conformed-name": "LYONDELL PETROCHEMICAL CO", "date-changed": "19920703"}}
SECURITIES AND EXCHANGE COMMISSION
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 24, 2006
LYONDELL CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-10145								95-4160558
(Commission File Number)					(I.R.S. Employer Identification No.)
1221 McKinney Street, Suite 700, Houston, Texas			   77010
(Address of principal executive offices)				(Zip Code)
(713) 652-7200
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
The description set forth below is qualified in its entirety by the full text of the respective document to which it refers, which document is filed herewith.
Item 1.01	Entry into a Material Definitive Agreement
Effective May 24, 2006, Millennium Chemicals Inc. ( "Millennium"), a wholly owned subsidiary of Lyondell Chemical Company ("Lyondell"), Millennium America Inc., a U.S. subsidiary of Millennium ("Millennium America") and Millennium Inorganic Chemicals Ltd, an Australian subsidiary of Millennium ("MIC Ltd"), entered into an amendment (the "Amendment") to the Credit Agreement (the "Credit Agreement"), dated August 22, 2005, among Millennium, Millennium America, MIC Ltd, the lenders party thereto including Bank of America, N.A. as Syndication Agent, JPMorgan Chase Bank, N.A. as Administrative Agent and Collateral Agent, and J.P. Morgan Securities Inc. and Banc of America Securities LLC as Co-Lead Arrangers and Joint Bookrunners.  The Amendment primarily revised the Credit Agreement to exclude Millennium Holdings, LLC and its subsidiaries (collectively, "Millennium Holdings"), a subsidiary of Millennium, from events-of-default provisions that could be triggered in connection with judgments against Millennium Holdings.  Lyondell has not guaranteed Millennium's or its subsidiaries' obligations under the Credit Agreement.  The Amendment is incorporated by reference into this Current Report on Form 8-K.
Item 9.01	Financial Statements and Exhibits
Exhibits
4.27(a)	Amendment No. 1 dated as of May 23, 2006 to Credit Agreement, dated August 22, 2005, among Millennium America Inc., as Borrower, Millennium Inorganic Chemicals Ltd, as Borrower,
Millennium Chemicals Inc.
, as Guarantor, the lenders from time to time party thereto, Bank of America, N.A., as Syndication Agent, JP Morgan Chase Bank, N.A. as Administrative Agent and Collateral Agent and JP Morgan Securities Inc. and Banc of America Securities LLC as Co-Lead Arrangers and Joint Bookrunners (filed as Exhibit 4.4(a) to Millennium's Current Report on Form 8-K dated as of May 24, 2006 and incorporated herein by reference)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LYONDELL CHEMICAL COMPANY
By:
/s/ Kerry A. Galvin
Name:	Kerry A. Galvin
Title:	Senior Vice President & General 									Counsel
Date:  May 24, 2006
INDEX TO EXHIBITS
Exhibit
Number
Description
4.27(a)	Amendment No. 1 dated as of May 23, 2006 to Credit Agreement, dated August 22, 2005, among Millennium America Inc., as Borrower, Millennium Inorganic Chemicals Ltd, as Borrower, Millennium Chemicals Inc., as Guarantor, the lenders from time to time party thereto, Bank of America, N.A., as Syndication Agent, JP Morgan Chase Bank, N.A. as Administrative Agent and Collateral Agent and JP Morgan Securities Inc. and Banc of America Securities LLC as Co-Lead Arrangers and Joint Bookrunners (filed as Exhibit 4.4(a) to Millennium's Current Report on Form 8-K dated as of May 24, 2006 and incorporated herein by reference)